HEMODRAG® 20 mL - Injectable solution
Hemostatic and Angioprotective.
Hemodrag® is indicated for the prevention and treatment of bleeding in veterinary surgery, reproductive pathologies and obstetrics, accidental traumatology and localized bleeding in various organs. It has a hemostatic and angioprotective effect on skin processes such as petechiae, bruises and wounds.
Hemodrag® is effective for all bleeding processes whatever their etiology (with the exception of bleeding caused by coumarin agents), because it acts on primary haemostasis. It can be used in horse and bovine castration, tail docking and castration in pigs and in puerperal haemorrhage in cows and mares.
Technical Specification
Species
Bovine, horses and pigs.
Dosage form
Injectable solution.
Therapeutic action
Hemostatic and Angioprotective.
Composition
Each ml contains:
Etamsilate........................125 mg
Excipients q.s.p....................1 mL
Indications
Hemodrag® is indicated for the prevention and treatment of bleeding in veterinary surgery, reproductive pathologies and obstetrics, accidental traumatology and localized bleeding in various organs. It has a hemostatic and angioprotective effect on skin processes such as petechiae, bruises and wounds.
Hemodrag® is effective for all bleeding processes whatever their etiology (with the exception of bleeding caused by coumarin agents), because it acts on primary haemostasis. It can be used in horse and bovine castration, tail docking and castration in pigs and in puerperal haemorrhage in cows and mares.
Route od administration and dosage
Administration by slow intravenous or deep intramuscular route.
Dose of the active ingredient:
- Cattle, horses and pigs: 5 to 12.5 mg/Kg of weight, every six hours, for 1 to 3 days, as necessary.
Product dosage:
- Cattle, horses and pigs: 0.4 to 1 mL /10 kg of weight, every six hours, for 1 to 3 days, as necessary.
Drug interactions
Do not use concomitantly with other pharmacological products.
Contraindications
- Do not administer in cases of acute porphyriasis, since it has been seen to be porphyrogenic in animals.
- Do not use in animals with known hypersensitivity to the active substance.
Special precautions for use
Special warnings and precautions for use
- Keep out of the reach of children and pets.
- This product is indicated for the treatment of animals individually. Do not treat the entire mass of animals.
- Animals must not be slaughtered for human consumption during and/or immediately after treatment.
- The product oxidizes in the presence of Oxygen, therefore the remaining volume after administration must be discarded.
- In the case of intramuscular administration, if the required dose is greater than 20 mL, it is suggested to divide it into two or more points of application.
Special precautions for the operator
- Manage with caution. Wash hands after applying the product.
- People with known hypersensitivity to ethamsylate should avoid contact with the drug.
- Accidental self-injection may cause alteration of blood pressure. In case of occurrence, consult a doctor immediately and show the product label.
Adverse effects
They have not been described.
Guard period
Meat: 0 days.
Milk: 0 days.
Observations
Overdose:
Studies carried out on the tolerance of ethamsylate indicate that it is well tolerated even in doses much higher than those recommended.
Special precautions for disposal of unused product or waste material:
Discard the remains of unused product in its original container. Do not throw the empty container or with remains of the product in rivers, lakes or streams of natural water. Dispose of this product carefully with your household waste.
Conservation
Store at room temperature, between 15 and 30 °C, in a dry place protected from light.
Once the container is opened, use within 1 week. Discard unused product after that period of time.
Condition of sale
To be supply only on veterinary prescription.
Presentation
Ampule with 20 mL
Prepared by
Drag Pharma Laboratory.
Records
Chile: SAG Reg. No. 1967
Peru: Reg. SENASA F.F3.01.I.0009
Imported and Distributed by Representaciones Durand SAC.
Av. Manuel Olguín N° 501 Office N° 604 Santiago de Surco Lima.
Costa Rica: Reg. No. MV-7150
Countries where it is marketed
Imported and Distributed in Peru by:
Representations Durand SAC.
Av. Manuel Olguín N° 501 Office N° 604 Santiago de Surco Lima.
You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).
Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian